Skip to content
BMarker
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
Menu
TransactionsPerformanceSharingStocks & ETFsDemoPricingAPI Docs
Open app
  • TT vs GSK✓SelectedUSD · GSKTT vs GSK performance historyLatest closeAs of-1.94%11/19
Stock and ETF performance explorer

TT vs GSK

vs
1w1mo3mo6mo1y3y5y10yallcustom
Portfolio return
+703.5%
GSK return
+97.7%
Excess return
+605.9%
Maximum drawdown
-40.5%

Performance

Returns, benchmark comparison, and relative performance.

Performance by timeframe

Returns for 10y.

Portfolio and benchmark returns by period
PeriodPortfolioGSKExcessAlpha
1D-1.9%-1.6%-0.4%-1.5%
7D-5.2%-4.7%-0.5%-4.0%
30D-12.9%-4.7%-8.2%-11.9%
3M-11.6%-8.8%-2.8%-9.6%
6M-9.9%-4.6%-5.3%-9.4%
YTD+4.0%+1.0%+3.0%+2.5%
1Y-0.5%+6.9%-7.4%-3.6%
3Y+80.7%+52.5%+28.2%+51.6%
5Y+117.8%+40.3%+77.5%+85.3%
All+703.5%+97.7%+605.9%+518.9%

Cumulative growth

Daily Returns

Daily percentage return beside GSK.

Daily Out/Under-Performance

Portfolio return minus GSK return. Positive bars indicate outperformance.

Daily Alpha

Portfolio daily return minus β × GSK return. Early observations use the first valid beta; later observations use the trailing beta estimated for each date.

Cumulative Out/Under-Performance

Relative wealth over 10y: compounded portfolio wealth divided by compounded GSK wealth, less one. Both series rebase at the selected span's start.

Cumulative Alpha

Compounded beta-adjusted residual returns apply the first valid beta to early observations, then the trailing beta ending on each date.

Updating return analytics…

10y analysis · Full analysis span regression · 6 months rolling